Legal & General Group PLC Ocular Therapeutix, Inc Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Legal & General Group PLC holds 104,783 shares of OCUL stock, worth $733,481. This represents 0.0% of its overall portfolio holdings.

Number of Shares

104,783

Previous 114,079 8.15%

Holding current value

$733,481

Previous $992,000 9.88%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$8.33 - $11.47 $77,435 - $106,625	-9,296 Reduced 8.15%	104,783 $894,000
Q3 2024 Nov 14, 2024	BUY	$6.45 - $9.23 $31,888 - $45,633	4,944 Added 4.53%	114,079 $992,000
Q2 2024 Aug 14, 2024	BUY	$4.2 - $8.69 $407,488 - $843,112	97,021 Added 800.9%	109,135 $746,000
Q1 2024 May 14, 2024	BUY	$3.85 - $10.93 $14,017 - $39,796	3,641 Added 42.97%	12,114 $110,000
Q4 2023 Feb 15, 2024	SELL	$2.08 - $4.52 $906 - $1,970	-436 Reduced 4.89%	8,473 $37,000
Q3 2023 Nov 14, 2023	SELL	$3.14 - $5.04 $2,276 - $3,654	-725 Reduced 7.53%	8,909 $27,000
Q2 2023 Aug 14, 2023	BUY	$4.6 - $7.64 $1,499 - $2,490	326 Added 3.5%	9,634 $49,000
Q1 2023 May 15, 2023	BUY	$2.79 - $6.27 $1,224 - $2,752	439 Added 4.95%	9,308 $49,000
Q3 2022 Nov 14, 2022	SELL	$4.09 - $6.5 $1,562 - $2,483	-382 Reduced 4.13%	8,869 $37,000
Q2 2022 Aug 22, 2022	SELL	$3.01 - $5.22 $133,339 - $231,240	-44,299 Reduced 82.72%	9,251 $37,000
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $120,107 - $235,340	19,498 Added 57.26%	53,550 $374,000
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $121,570 - $179,723	12,533 Added 58.24%	34,052 $341,000
Q2 2021 Aug 12, 2021	BUY	$13.43 - $19.16 $2,323 - $3,314	173 Added 0.81%	21,519 $305,000
Q1 2021 May 17, 2021	SELL	$15.82 - $22.11 $1,803 - $2,520	-114 Reduced 0.53%	21,346 $350,000
Q4 2020 Feb 12, 2021	BUY	$7.91 - $22.95 $112,662 - $326,876	14,243 Added 197.35%	21,460 $445,000
Q3 2020 Nov 13, 2020	SELL	$7.36 - $9.87 $9,104 - $12,209	-1,237 Reduced 14.63%	7,217 $55,000
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $7,700 - $14,758	1,649 Added 24.23%	8,454 $70,000
Q1 2020 May 14, 2020	SELL	$3.95 - $7.4 $6,138 - $11,499	-1,554 Reduced 18.59%	6,805 $34,000
Q4 2019 Feb 13, 2020	BUY	$2.57 - $4.73 $4,322 - $7,955	1,682 Added 25.19%	8,359 $33,000
Q1 2019 May 15, 2019	BUY	$3.51 - $4.77 $6,440 - $8,752	1,835 Added 37.9%	6,677 $27,000
Q2 2018 Aug 10, 2018	SELL	$5.99 - $8.17 $1,443 - $1,968	-241 Reduced 4.74%	4,842 $33,000
Q1 2018 May 17, 2018	SELL	$4.66 - $7.08 $4,156 - $6,315	-892 Reduced 14.93%	5,083 $33,000
Q4 2017 Feb 13, 2018	BUY	$3.73 - $6.37 $22,286 - $38,060	5,975	5,975 $27,000

Others Institutions Holding OCUL

# of Institutions

190

Shares Held

132M

Call Options Held

374K

Put Options Held

179K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $539M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Ocular Therapeutix, Inc Transaction History